Tivic Health Systems, Inc.
$1.13
▼
-1.01%
2026-04-21 09:49:00
tivichealth.com
NCM: TIVC
Explore Tivic Health Systems, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.25 M
Current Price
$1.13
52W High / Low
$13.23 / $0.72
Stock P/E
—
Book Value
$6.65
Dividend Yield
—
ROCE
-25.51%
ROE
-82.69%
Face Value
—
EPS
$-6.92
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
52
Beta
1.84
Debt / Equity
38.42
Current Ratio
20.13
Quick Ratio
20.13
Forward P/E
-0.04
Price / Sales
—
Enterprise Value
$-3.51 M
EV / EBITDA
0.45
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Accuray Incorporated | $0.46 | — | $52.79 M | — | 2.82% | -70.32% | $2.1 / $0.33 | $0.45 |
| 2. | Outset Medical, Inc. | $4.61 | — | $84.32 M | — | -29.4% | -1.06% | $21.98 / $3 | $6.99 |
| 3. | Xtant Medical Holdings, Inc. | $0.5 | 15.1 | $75.1 M | — | 11.26% | 10.59% | $0.95 / $0.39 | $0.36 |
| 4. | Cytek Biosciences, Inc. | $4.57 | — | $592.62 M | — | -10.52% | -18.05% | $6.18 / $2.37 | $2.66 |
| 5. | Quanterix Corporation | $3.3 | — | $164.29 M | — | -31.92% | -34.25% | $8.77 / $3.23 | $6.33 |
| 6. | Sensus Healthcare, Inc. | $4.06 | — | $66.84 M | — | -21.33% | -14.85% | $5.92 / $3.03 | $1.57 |
| 7. | Penumbra, Inc. | $333.46 | 73.7 | $13.1 B | — | 11.52% | 13.78% | $362.41 / $221.26 | $36.39 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | -0.3 M | 0.15 M | 0.09 M | 0.07 M | 0.18 M | — |
| Operating Profit | -1.98 M | -2.48 M | -1.93 M | -1.51 M | -1.54 M | — |
| Net Profit | -2.85 M | -2.6 M | -1.93 M | -1.5 M | -1.48 M | — |
| EPS in Rs | -0.99 | -0.9 | -0.67 | -0.52 | -0.51 | -3.93 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 1.18 M | 1.84 M |
| Operating Profit | -7.9 M | -4.48 M | -8.24 M | -10.1 M |
| Net Profit | -8.88 M | -5.66 M | -8.24 M | -10.1 M |
| EPS in Rs | -3.08 | -1.96 | -2.86 | -3.51 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 31.61 M | 2.81 M | 5.16 M | 5.88 M |
| Total Liabilities | 14.81 M | 0.27 M | 1.58 M | 2.25 M |
| Equity | 16.8 M | 2.54 M | 3.58 M | 3.63 M |
| Current Assets | 13.01 M | 2.64 M | 4.65 M | 5.31 M |
| Current Liabilities | 0.65 M | 0.27 M | 1.4 M | 1.88 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -7 M | -5.72 M | -8.51 M | -8.92 M |
| Investing CF | -0.7 M | 0 M | -0.12 M | -0.01 M |
| Financing CF | 18.35 M | 4.33 M | 8.51 M | -0.53 M |
| Free CF | -7.58 M | -5.72 M | -8.63 M | -8.93 M |
| Capex | -0.58 M | — | -0.12 M | -0.01 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -100% | -36.09% | — | — |
| Earnings Growth % | 31.4% | 18.34% | — | — |
| Profit Margin % | — | -701.02% | -548.7% | — |
| Operating Margin % | — | -701.11% | -548.8% | — |
| Gross Margin % | — | 24.4% | 16.25% | — |
| EBITDA Margin % | — | -685.63% | -539.35% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-03-07 | 1:0.0588235 |
| 2023-08-23 | 1:0.01 |